sertindole has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nawwar, DA; Sayed, RH; Zaki, HF | 1 |
1 other study(ies) available for sertindole and gamma-aminobutyric acid
| Article | Year |
|---|---|
Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamates; Humans; Imidazoles; Indoles; Ketamine; Male; Neuregulin-1; Parvalbumins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, ErbB-4; RNA, Messenger; Schizophrenia; Signal Transduction; Sucrose; TOR Serine-Threonine Kinases | 2022 |